Target Price | €60.81 |
Price | €53.50 |
Potential | 13.67% |
Number of Estimates | 18 |
18 Analysts have issued a price target Siemens Healthineers 2025 . The average Siemens Healthineers target price is €60.81. This is 13.67% higher than the current stock price. The highest price target is €72.90 36.26% , the lowest is €48.00 10.28% . | |
A rating was issued by 18 analysts: 16 Analysts recommend Siemens Healthineers to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Siemens Healthineers stock has an average upside potential 2025 of 13.67% . Most analysts recommend the Siemens Healthineers stock at Purchase. |
17 Analysts have issued a sales forecast Siemens Healthineers 2024 . The average Siemens Healthineers sales estimate is €22.7b . This is 3.63% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €23.0b 5.12% , the lowest is €22.5b 2.89% .
This results in the following potential growth metrics:
2023 | €21.7b | 0.16% |
---|---|---|
2024 | €22.7b | 4.53% |
2025 | €24.2b | 6.97% |
2026 | €25.8b | 6.52% |
2027 | €27.6b | 6.76% |
2028 | €29.5b | 6.96% |
15 Analysts have issued an Siemens Healthineers EBITDA forecast 2024. The average Siemens Healthineers EBITDA estimate is €4.6b . This is 10.17% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €4.9b 19.17% , the lowest is €4.2b 1.98% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €4.0b | 9.28% |
---|---|---|
2024 | €4.6b | 14.22% |
2025 | €5.3b | 16.86% |
2026 | €5.9b | 10.26% |
2027 | €6.6b | 11.40% |
2028 | €7.2b | 9.44% |
2023 | 18.44% | 9.14% |
---|---|---|
2024 | 20.15% | 9.29% |
2025 | 22.01% | 9.23% |
2026 | 22.78% | 3.50% |
2027 | 23.78% | 4.39% |
2028 | 24.33% | 2.31% |
14 Siemens Healthineers Analysts have issued a net profit forecast 2024. The average Siemens Healthineers net profit estimate is €2.0b . This is 10.65% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.5b 34.43% , the lowest is €1.8b 2.44% .
This results in the following potential growth metrics and future Net Margins:
2023 | €1.5b | 25.82% |
---|---|---|
2024 | €2.0b | 34.41% |
2025 | €2.6b | 27.17% |
2026 | €3.0b | 15.49% |
2027 | €3.4b | 14.94% |
2028 | €4.0b | 17.04% |
2023 | 6.97% | 25.71% |
---|---|---|
2024 | 8.96% | 28.64% |
2025 | 10.65% | 18.86% |
2026 | 11.55% | 8.45% |
2027 | 12.43% | 7.62% |
2028 | 13.60% | 9.41% |
14 Analysts have issued a Siemens Healthineers forecast for earnings per share. The average Siemens Healthineers <a href=/blog/eps>EPS is €1.81 . This is 10.37% higher than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is €2.20 34.15% , the lowest is €1.60 2.44% .
This results in the following potential growth metrics and future valuations:
2023 | €1.35 | 25.82% |
---|---|---|
2024 | €1.81 | 34.07% |
2025 | €2.31 | 27.62% |
2026 | €2.67 | 15.58% |
2027 | €3.06 | 14.61% |
2028 | €3.59 | 17.32% |
Current | 32.53 | 16.35% |
---|---|---|
2024 | 29.48 | 9.38% |
2025 | 23.19 | 21.34% |
2026 | 20.07 | 13.45% |
2027 | 17.47 | 12.95% |
2028 | 14.92 | 14.60% |
Based on analysts' sales estimates for 2024, the Siemens Healthineers stock is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of 3.26 and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of 2.64 .
This results in the following potential growth metrics and future valuations:
Current | 3.38 | 0.00% |
---|---|---|
2024 | 3.26 | 3.47% |
2025 | 3.05 | 6.51% |
2026 | 2.86 | 6.12% |
2027 | 2.68 | 6.33% |
2028 | 2.51 | 6.51% |
Current | 2.74 | 1.86% |
---|---|---|
2024 | 2.64 | 3.50% |
2025 | 2.47 | 6.51% |
2026 | 2.32 | 6.12% |
2027 | 2.17 | 6.33% |
2028 | 2.03 | 6.51% |
Siemens Healthineers...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.